OCTOBER 2006

• 10/12/2006
  Abhimanyu Garg, MD
  Lipodystrophy and obesity: Metabolic extremes with similar outcomes.
• 10/19/2006
  Craig Malloy, MD
  Role of skeletal mitochondria in Type 2 diabetes mellitus.
• 10/26/2006
  Nicola Abate, MD
  Metabolic and genetic determinants of insulin resistance.

NOVEMBER 2006

• 11/2/2006
  Jeffrey Browning, MD
  The impact of dietary macronutrient composition on hepatic metabolism and energetics.
• 11/9/2006
  Darren McGuire, M.D., MHSc
  Cardiovascular effects of rosiglitazone vs. placebo: A work in progress.
• 11/16/2006
  Roger Unger, MD Suicide by beta cells: The primacy of hyperinsulinemia in beta cell damage (T2D) and other defects of the metabolic syndrome.
• 11/30/2006
  Lidia Szczepaniak, PhD
  Ectopic fat accumulation: Is it bad? Is it ugly? How to reduce it?

DECEMBER 2006

• 12/7/2006
  Joel Elmquist, D.V.M., Ph.D.
  Hypothalamic control of coordinated body weight and glucose homeostasis.
• 12/14/2006
  Elizabeth Parks, PhD
  The effect of dietary fructose and sucrose on fatty acid synthesis in healthy humans.
• 12/21/2006
  Edward Livingston, MD
  Metabolic complications of severe obesity.
• 12/28/2006
  Steven Kliewer, PhD
  Nuclear receptors, fibroblast growth factors, and metabolism.

JANUARY 2007

• 1/4/2007
  Lidia Szczepaniak, PhD
  Ectopic fat accumulation: Is it bad? Is it ugly? How to reduce it?
• 1/11/2007
  Scott Grundy, MD, PhD
  Influence of body fat content and distribution on variation in metabolic risk.
• 1/25/2007
  Amit Khera, M.D., M.Sc.
  C‐reactive protein and obesity: Understanding associations and applications.

FEBRUARY 2007

• 2/1/2007
  Jonathan Cohen, PhD
  Genetic analysis of the Dallas Heart Study.
• 2/8/2007
  Samuel Klein, MD
  Fatty acid pathophysiology in obesity.
• 2/15/2007
  John Miles, MD
  Spillover of lipoprotein lipase‐generated fatty acids into plasma.
• 2/22/2007
  Joyce Repa, PhD
  Nuclear hormone receptors and the endocrine pancreas.

MARCH 2007

• 3/1/2007
  Ronald Haller, MD
  When good mitochondria go bad: the pathophysiology of mitochondrial myopathy.
• 3/15/2007
  Andrew Zinn, MD, PhD
  Cytogenetic Obesity: A SIMple story.
• 3/22/2007
  Manisha Chandalia, MD
  Ethnicity, fat distribution and insulin resistance.
• 3/29/2007
  Elizabeth Murphy, MD
  Stable isotope studies of insulin resistance and beta cell function.

APRIL 2007

• 4/5/2007
  Joachim Herz, MD
  Molecular genetics of LDL receptors.
• 4/12/2007
  Horacio Rodriguez Rilo, M.D.
  FASTS Islet transplantation: Hype or hope?
• 4/19/2007
  Ko Uyeda, PhD
  Deficiency of carbohydrate‐activated transcription factor ChREBP prevents obesity and improves plasma glucose contraol in leptin‐deficient (ob/ob) mice.
• 4/26/2007
  Barjor Gimi, PhD
  Novel strategies for islet encapsulation and functional magnetic resonance microscopy of islets.

MAY 2007

• 5/3/2007
  Leon Avery, PhD, MBA Molecular basis of feeding regulation
• 5/10/2007
  Paul O'Brien, MD
  Diabesity and weight loss: an approach to a solution.
• 5/17/2007
  Raymond MacDonald, PhD
  Signaling and transcriptional control of pancreatic organogenesis.
• 5/24/2007
  Vinaya Simha, MD
  Leptin treatment of lipodystrophy in HIV.
• 5/29/2007
  Deborah Clegg, PhD
  Estrogen and the hypothalamic regulation of energy balance.
• 5/30/2007
  Samuel Cushman, PhD
  Role of dysfunctional adipogenesis in insulin resistance.
• 5/31/2007
  Fred Sacks, MD
  Apolipoprotein C‐III: Modulator of apoB metabolism and direct pro‐atherogenic protein in humans.

JUNE 2007

• 6/7/2007
  Roberto Coppari, MD
  Physiological relevance of metabolic sensing in restricted populations of hypothalamic neurons.
• 6/14/2007
  Vincent Mooser, MD
  Molecular dissection of cardiovascular risk factors in GEMS and in the Lausanne population‐based study.
• 6/21/2007
  Patricia Iozzo, MD, PhD
  Use of PET in the study of organ metabolism with special reference to the liver.
• 6/28/2007
  David Barker, MD, PhD, FRS
  Early growth and disease in later life.

JULY 2007

• 7/5/2007
  Alice Chang, MD
  Associations among androgens, estrogens, and natriuretic peptides in young women.
• 7/12/2007
  Shawn Burgess, PhD
  The role of hepatic energy metabolism in regulating hepatic gluconeogenesis.
• 7/19/2007
  Kevin Oeffinger, MD
  Obesity, insulin resistance, and cardiovascular risk in survivors of childhood lukemia.
• 7/26/2007
  Richard Auchus, MD, PhD
  Dysregulation of cortisol balance in obesity and the metabolic syndrome, from molecules to man.

AUGUST 2007

• 8/2/2007
  John Dietschy, MD
  Cholesterol metabolism in the brain and neurodegeneration.
• 8/30/2007
  Anthony Cerami, PhD
  TNF and erythropoietin: The Lucifer and Gabriel cytokines.

SEPTEMBER 2007

• 9/6/2007
  Richard Anderson, PhD
  Great balls of fat.
• 9/12/2007
  Steven Haffner, MD
  Does rosiglitazone markedly increase the risk of CHD: The good, the bad, and the ugly.
• 9/13/2007
  David Reich, PhD
  Admixture mapping of cardiovascular and quantitative traits.
• 9/20/2007
  Eric Nestler, MD, PhD
  Molecular mechanisms of addiction.
• 9/27/2007
  James de Lemos, MD
  The association of differing measures of overweight and obesity with prevalent atherosclerosis: The Dallas Heart Study.

OCTOBER 2007

• 10/4/2007
  Ildiko Lingvay, MD, MPH
  The rise and demise of beta cells.
• 10/11/2007
  Mark Drazner, MD
  Left ventricular hypertrophy: Insights from the Dallas Heart Study.
• 10/18/2007
  Jeffrey Zigman, MD, PhD
  Ghrelin and motived behaviors.
• October 25, 2007
  Vinaya Simha, M.D.
  Metabolic Consequences of Bariatric Surgery

_______________________________________________________________________________